Oxidative stress, erythrocyte ageing and plasma non-protein-bound iron in diabetic patients

Free Radical Research

Volumn 42, Issue 8, 2008, Pages 716-724

  Leoncini, Silvia ^a   Rossi, Viviana ^a   Signorini, Cinzia ^a   Tanganelli, Italo ^a   Comporti, Mario ^a   Ciccoli, Lucia ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Diabetes; Erythrocytes; F2 isoprostanes; Oxidative damage; Oxidative stress; Redox active iron

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; DEFEROXAMINE; HEMOGLOBIN A1C; IMMUNOGLOBULIN G; IRON; ISOPROSTANE DERIVATIVE; METFORMIN; METHEMOGLOBIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ARTICLE; CELL ASSAY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; ERYTHROCYTE LIFESPAN; FEMALE; HEMOGLOBIN SYNTHESIS; HUMAN; IRON BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PROTEIN BINDING;

AGED; CASE-CONTROL STUDIES; DEFEROXAMINE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ERYTHROCYTE AGING; ERYTHROCYTES; F2-ISOPROSTANES; FEMALE; HUMANS; IRON; MALE; METHEMOGLOBIN; MIDDLE AGED; OXIDATIVE STRESS; PROTEIN BINDING;

EID: 50849094839     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.1080/10715760802317655     Document Type: Article

References (54)

1. Signorini, C., Ferrali, M., Ciccoli, L., Sugherini, L., Magnani, A. and Comporti, M. (1995) Iron release, membrane protein oxidation and erythrocyte ageing. FEBS Lett, 362, pp. 165-170.
2. Comporti, M., Signorini, C., Buonocore, G. and Ciccoli, L. (2002) Iron release, oxidative stress and erythrocyte ageing. Free Radic Biol Med, 32, pp. 568-576.
3. Turrini, F., Mannu, F., Cappadoro, M., Ulliers, D., Giribaldi, G. and Arese, P. (1994) Binding of naturally occurring antibodies to oxidatively and nonoxidatively modified erythrocyte band 3. Biochim Biophys Acta, 1190, pp. 297-303.
4. Ferrali, M., Ciccoli, L. and Comporti, M. (1989) Allyl alcohol-induced hemolysis and its relation to iron release and lipid peroxidation. Biochem Pharmacol, 38, pp. 1819-1825.
5. Ferrali, M., Signorini, C., Ciccoli, L. and Comporti, M. (1992) Iron release and membrane damage in erythrocytes exposed to oxidizing agents, phenylhydrazine, divicine and isouramil. Biochem J, 285, pp. 295-301.
6. Ciccoli, L., Signorini, C., Scarano, C., Rossi, V., Bambagioni, S., Ferrali, M. and Comporti, M. (1999) Iron release in erythrocytes from patients with beta-thalassemia. Free Radic Res, 30, pp. 407-413.
7. Ciccoli, L., Rossi, V., Leoncini, S., Signorini, C., Paffetti, P., Bracci, R., Buonocore, G. and Comporti, M. (2003) Iron release in erythrocytes and plasma non protein-bound iron in hypoxic and non hypoxic newborns. Free Radic Res, 37, pp. 51-58.
8. Pearson, HA. (1967) Life-span of the fetal red blood cell. J Pediatr, 70, pp. 166-171.
9. Rossi, V., Leoncini, S., Signorini, C., Buonocore, G., Paffetti, P., Tanganelli, D., Ciccoli, L. and Comporti, M. (2006) Oxidative stress and autologous immunoglobulin G binding to band 3 dimers in newborn erythrocytes. Free Radic Biol Med, 40, pp. 907-915.
10. Milne, GL, Musiek, ES and Morrow, JD. (2005) F2-isoprostanes as markers of oxidative stress in vivo: An overview. Biomarkers, 10, pp. S10-S23.
11. Comporti, M., Signorini, C., Leoncini, S., Buonocore, G., Rossi, V. and Ciccoli, L. (2004) Plasma F2-isoprostanes are elevated in newborns and inversely correlated to gestational age. Free Radic Biol Med, 37, pp. 724-732.
12. Jay, D., Hitomi, H. and Griendling, KK. (2006) Oxidative stress and diabetic cardiovascular complications. Free Radic Biol Med, 40, pp. 183-192.
13. Davi, G., Falco, A. and Patrono, C. (2005) Lipid peroxidation in diabetes mellitus. Antiox Redox Signals, 7, pp. 256-268.
14. Halliwell, B. and Gutteridge, JMC. (1999) Free radicals, other reactive species and disease. Free radicals in biology and medicine, pp. 617-783. Clarendon Press, Oxford
15. Sailaja, YR, Baskar, R. and Saralakumari, D. (2003) The antioxidant status during maturation of reticulocytes to erythrocytes in type 2 diabetics. Free Radic Biol Med, 35, pp. 133-139.
16. Babu, N. and Singh, M. (2004) Influence of hyperglycemia on aggregation, deformability and shape parameters of erythrocytes. Clin Hemorheol Microcirc, 31, pp. 273-280.
17. Wautier, JL, Wautier, MP, Schmidt, M., Anderson, GM, Hori, O., Zoukourian, C., Capron, L., Chappey, O., Yan, SD, Brett, J., Guillausseau, PJ and Stern, D. (1994) Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: A link between surface-associated AGEs and diabetic complications. Proc Natl Acad Sci USA, 91, pp. 7742-7746.
18. Berger, HM, Mumby, S. and Gutteridge, JMC. (1995) Ferrous ions detected in iron-overloaded cord blood plasma from preterm and term babies: implications for oxidative stress. Free Radic Res, 22, pp. 555-559.
19. Loreal, O., Gosriwatana, I., Guyader, D., Porter, J., Brissot, P. and Hider, RC. (2000) Determination of non-transferrin-bound iron in genetic hemochromatosis using a new HPLC-based method. J Hepatol, 32, pp. 727-733.
20. Gosriwatana, I., Loreal, O., Lu, S., Brissot, P., Porter, J. and Hider, RC. (1999) Quantification of non-transferrin-bound iron in the presence of unsaturated transferrin. Anal Biochem, 273, pp. 212-220.
21. Fernandez-Real, JM, Lopez-Bermejo, A. and Ricart, W. (2002) Cross-talk between iron metabolism and diabetes. Diabetes, 51, pp. 2348-2354.
22. Swaminathan, S., Fonseca, VA, Alam, MG and Shah, SV. (2007) The role of iron in diabetes and its complications. Diabetes Care, 30, pp. 1926-1933.
23. Sulieman, M., Asleh, R., Cabantchik, ZI, Breuer, W., Aronson, D., Sulieman, A., Miller-Lotan, R., Hammerman, H. and Levy, AP. (2004) Serum chelatable redox-active iron is an independent predictor of mortality after myocardial infarction in individuals with diabetes. Diabetes Care, 27, pp. 2730-2732.
24. Lee, DH, Liu, DY, Jacobs Jr, DR, Shin, HR, Song, K., Lee, IK, Kim, B. and Hider, RC. (2006) Common presence of non-transferrin-bound iron among patients with type 2 diabetes. Diabetes Care, 29, pp. 1090-1095.
25. Witko-Sarsat, V., Friedlander, M., Capeillere-Blandin, C., Nguyen-Khoa, T., Thu Nguyen, A, Zingraff, J., Jungers, P. and Descamps-Latsca, B. (1996) Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int, 49, pp. 1304-1313.
26. American Diabetes Association (2006) Nutrition recommendations and interventions for diabetes-2006: A position statement of the American Diabetes Association. Diabetes Care, 29, pp. 2140-2157.
27. Evelyn, KA and Malloy, HT. (1938) Microdetermination of oxyhemoglobin, methemoglobin and sulfhemoglobin in a single sample of blood. J Biol Chem, 26, pp. 655-662.
28. Dodge, TG, Mitchell, RG and Hanahan, DJ. (1963) The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch Biochem Biophys, 100, pp. 119-130.
29. Lowry, OH, Rosebrough, NJ, Farr, AL and Randall, RJ. (1951) Protein measurement with the Folin phenol reagent. J Biol Chem, 193, pp. 265-275.
30. Laemmli, UK. (1970) Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature, 227, pp. 680-685.
31. Towbin, H., Staehlin, R. and Fordon, J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA, 6, pp. 4350-4354.
32. Nourooz-Zadeh, J., Gopaul, NK, Barrow, S., Mallet, AI and Anggård, EE. (1995) Analysis of F2-isoprostanes as indicators of non-enzymatic lipid peroxidation in vivo by gas chromatography-mass spectrometry: development of a solid-phase extraction procedure. J Chromatogr B Biomed Appl, 667, pp. 199-208.
33. Signorini, C., Comporti, M. and Giorgi, G. (2003) Ion trap tandem mass spectrometric determination of F2-isoprostanes. J Mass Spectrom, 38, pp. 1067-1074.
34. Bradford, MM. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem, 72, pp. 248-254.
35. Kay, MMB, Goodman, SR, Sorensen, K., Whitfield, CF, Wong, P., Zaki, L. and Rudloff, V. (1983) Senescent cell antigen is immunologically related to band 3. Proc Natl Acad Sci USA, 80, pp. 1631-1635.
36. Hornig, R. and Lutz, HU. (2000) Band 3 protein clustering on human erythrocytes promotes binding of naturally occurring anti-band 3 and anti-spectrin antibodies. Exp Gerontol, 35, pp. 1025-1044.
37. Low, PS. (1991) Role of hemoglobin denaturation and band 3 clustering in initiating red cell removal. Adv Exp Med Biol, 307, pp. 173-183.
38. Arese, P., Turrini, F. and Schwarzer, E. (2005) Band 3/ complement-mediated recognition and removal of normally senescent and pathological human erythrocytes. Cell Physiol Biochem, 16, pp. 133-146.
39. Ciccoli, L., Rossi, V., Leoncini, S., Signorini, C., Blanco-Garcia, J., Aldinucci, C., Buonocore, G. and Comporti, M. (2004) Iron release, superoxide production and binding of autologous IgG to band 3 dimers in newborn and adult erythrocytes exposed to hypoxia and hypoxia-reoxygenation. Biochim Biophys Acta, 1672, pp. 203-213.
40. Nagababu, E., Ramasamy, S. and Rifkind, JM. (2002) Site-specific cross-linking of human and bovine hemoglobins differentially alters oxygen binding and redox side reactions producing rhombic heme and heme degradation. Biochemistry, 41, pp. 7407-7415.
41. Repka, T., Shalev, O., Reddy, R., Yuan, J., Abrahmov, A., Rachmilewitz, EA, Low, PS and Hebbel, RP. (1993) Nonrandom association of free iron with membranes of sickle and β-thalassemic erythrocytes. Blood, 82, pp. 3204-3210.
42. Browne, P., Shalev, O. and Hebbel, RB. (1998) The molecular pathobiology of cell membrane iron: The sickle red cell as a model. Free Radic Biol Med, 24, pp. 1040-1048.
43. Kar, M. and Chakraborti, AS. (1999) Release of iron from haemoglobin-a possible source of free radicals in diabetes mellitus. Indian J Exp Biol, 37, pp. 190-192.
44. Sen, S., Kar, M., Roy, A. and Chakraborti, AS. (2005) Effect of nonenzymatic glycation on functional and structural properties of hemoglobin. Biophys Chem, 113, pp. 289-298.
45. Cussimanio, BL, Booth, AA, Todd, P., Hudson, BG and Kahlifah, RG. (2003) Unusual susceptibility of heme proteins to damage by glucose during non-enzymatic glycation. Biophys Chem, 105, pp. 743-755.
46. Gutteridge, JM, Rowley, DA and Halliwell, B. (1981) Superoxide-dependent formation of hydroxyl radicals in the presence of iron salts. Detection of 'free' iron in biological systems by using bleomycin-dependent degradation of DNA. Biochem J, 199, pp. 263-265.
47. Yuan, XM and Li, W. (2003) The iron hypothesis of atherosclerosis and its clinical impact. Ann Med, 35, pp. 578-591.
48. Gopaul, NK, Anggård, EE, Mallet, AI, Betteridge, DJ, Wolff, SP and Nourooz-Zadeh, J. (1995) Plasma 8-epi-PGF2 alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus. FEBS Lett, 368, pp. 225-229.
49. Salahudeen, AK, Oliver, B., Bower, JD and Roberts, LJ II. (2001) Increase in plasma esterified F2-isoprostanes following intravenous iron infusion in patients on hemodialysis. Kidney Int, 60, pp. 1525-1531.
50. Signorini, C., Perrone, S., Sgherri, C., Ciccoli, L., Buonocore, G., Leoncini, S., Rossi, V., Vecchio, D. and Comporti, M. (2008) Plasma esterified F2-Isoprostanes and oxidative stress in newborns. Role of non protein bound iron. Pediat Res, 63, pp. 287-291.
51. Devaraj, S., Hirany, SV, Burk, RF and Jialal, I. (2001) Divergence between LDL oxidative susceptibility and urinary F(2)-isoprostanes as measures of oxidative stress in type 2 diabetes. Clin Chem, 47, pp. 1974-1979.
52. Feillet-Coudray, C., Chone, F., Michel, F., Rock, E., Thieblot, P., Rayssiguier, Y., Tauveron, I. and Mazur, A. (2002) Divergence in plasmatic and urinary isoprostane levels in type 2 diabetes. Clin Chim Acta, 324, pp. 25-30.
53. Selmeci, L., Seres, L., Antal, M., Lukacs, J., Regoly-Merei, A. and Acsady, G. (2005) Advanced oxidation protein products (AOPP) for monitoring oxidative stress in critically ill patients: A simple, fast and inexpensive automated technique. Clin Chem Lab Med, 43, pp. 294-297.
54. Kalousova, M., Skrha, J. and Zima, T. (2002) Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res, 51, pp. 597-604.